1.Analysis of Cardiovascular Disease Burden in China and Globally Based on GBD Data
Wenjing XIONG ; Qian LIU ; Xia WU ; Tingyu ZHU ; Hong AN ; Fengxia ZHANG ; Weiqing RANG ; Jianfeng LIU
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2026;55(5):666-673
Objective To systematically assess the burden of cardiovascular diseases (CVDs) globally and in China from 1990 to 2021 using data from the Global Burden of Disease (GBD) 2021 study, and to evaluate temporal trends, cause-of-death composition, years of life lost (YLL) contribution, and age-period-cohort effects, so as to provide a scientific basis for differentiated prevention and treatment strategies. Methods CVD data for the globe and China from 1990 to 2021 were extracted from the GBD 2021 database, including incidence, mortality, age-standardized mortality rate (ASMR), disability-adjusted life years (DALYs), YLL, and years lived with disability (YLD). The annual percentage change (APC) and average annual percentage change (AAPC) were calculated to analyze temporal trends. Pareto analysis was used to identify leading causes of death. YLL contribution was calculated to assess the contribution of each cause of death. An age-period-cohort model was constructed to quantify the effects of age, period, and birth cohort on CVD mortality. Results Temporal trend analysis: From 1990 to 2021, the relative changes in ASMR and age-standardized DALY rate for CVDs were negative for both the globe and China. The ASMR for CVDs showed a declining trend, with a greater decline globally (AAPC=-1.336%) than in China (AAPC=-1.216%). In both regions, the decline in mortality was smaller in males than in females. Cause-of-death composition analysis: From 1990 to 2021, CVDs were the leading cause of death globally and in China. Ischemic heart disease, stroke, and hypertensive heart disease were the top three causes of CVD deaths, collectively accounting for more than 80% of total CVD mortality; however, their rankings differed (globally: ischemic heart disease > stroke > hypertensive heart disease; in China: stroke > ischemic heart disease > hypertensive heart disease). Premature mortality burden analysis: Although the contribution of YLL showed a gradual decline over the years, it consistently remained at a high level of 90%.Age-period-cohort effects analysis: The results showed that the net drift, age, period, and cohort effects for global CVD mortality were all statistically significant (all P<0.05). The age effect exhibited a J-shaped increase with advancing age. Both period and cohort effects showed a sustained downward trend over time and across successive birth cohorts. Conclusion Although the age-standardized mortality burden of CVDs has declined overall in both the globe and China, the absolute burden continues to increase, and the problem of premature death remains substantial. China faces distinct challenges in terms of leading causes (stroke vs. ischemic heart disease) and gender disparities compared with the globe. Future prevention and control efforts should take into account the risk characteristics associated with specific ages, periods, and birth cohorts to develop precise and differentiated intervention strategies.
2.Application and exploration of single-incision plus one port laparoscopic surgery in radical resection of colorectal cancer
Yu ZHU ; Hao WANG ; Yanan WANG ; Haijun DENG ; Tingyu MOU
Chinese Journal of Digestive Surgery 2025;24(6):733-738
The surgical management of colorectal cancer has evolved from conventional multiport laparoscopic surgery toward more minimally invasive and individualized approaches. Among these, single-incision laparoscopic surgery (SILS) or reduced-port laparoscopic surgery (RPLS) has gained increasing attention from clinicians. Single-incision plus one port laparoscopic surgery (SILS+1) combines the advantages of both SILS and RPLS. Recent studies have demonstrated that compared with conventional multiport laparoscopic surgery, SILS+1 could yield comparable safety, feasibility and oncologic outcomes in treating colorectal cancer while offering additional benefits in enhanced recovery and better cosmesis.The development of SILS+1 relies heavily on innovations in single-port platforms and specialized instruments. By strictly adhering to its indica-tions, skillfully employing string and traction techniques during surgery, and the appropriate mana-gement of complications such as hemorrhage, the procedure can be performed safely and smoothly. The authors review relevant domestic and international studies and integrate the practical experi-ence to provide an in-depth discussion on the application and exploration of SILS+1 in radical colorectal cancer surgery, aiming to provide valuable insights for broader adoption of this approach.
3.Application progress of eye-tracking technology in the nursing field
Airong ZHU ; Shining CAI ; Tingyu GUAN ; Xizhu CHEN ; Yuxia ZHANG
Chinese Journal of Nursing 2025;60(20):2549-2552
Eye-tracking technology monitors eye movement trajectories to reveal the cognitive mechanisms underlying visual behavior.With advantages like objectivity and real-time capability,it is increasingly applied in nursing.However,research and application in China are still in the early stages.This article reviews the development,measurement metrics,methods,and impact of eye-tracking in nursing,analyzes current challenges,and suggests solutions to aid its development in the field of nursing in China.
4.Research progress in treatment of symptomatic non-acute middle cerebra artery arteriosclerosis occlusion
Chenyang HUANG ; Tingyu LIU ; Qingfeng ZHU
Clinical Medicine of China 2025;41(2):155-160
In the non-acute phase, when the collateral circulation is poorly compensated due to atherosclerotic occlusion of the middle cerebral artery, it can lead to significant neurological dysfunction and a higher recurrence rate of stroke. Traditional treatments primarily involve managing risk factors and administering symptomatic pharmacotherapy, yet the outcomes are often unsatisfactory. In recent years, with the development of endovascular interventional techniques and interventional materials, microsurgical anastomosis, techniques, and the present of distal ischemic modulation, the treatment of symptomatic arteriosclerosis occlusion of the non-acute middle cerebral artery is attracting more and more attention in the field. This article reviews the progress of the treatment of symptomatic arteriosclerosis occlusion of the non-acute middle cerebral artery. For the surgical treatment of symptomatic non-acute middle cerebral artery atherosclerosis occlusion (SNMCAO) in non-acute phase, the superior temporal artery middle cerebral artery (STA-MCA) low flow bypass and intravascular interventional recanalization have their own advantages. For patients with short expected occlusion time, short occlusion segment, straight blood vessels, and good distal vascular bed, they may be more inclined to undergo endovascular recanalization treatment, otherwise they may choose STA-MCA low flow bypass surgery. Regardless of which treatment method is chosen, precise individualized evaluation must be conducted before surgery to select an individualized surgical approach that can maximize the benefits for patients with SNMCAO.
5.Application progress of eye-tracking technology in the nursing field
Airong ZHU ; Shining CAI ; Tingyu GUAN ; Xizhu CHEN ; Yuxia ZHANG
Chinese Journal of Nursing 2025;60(20):2549-2552
Eye-tracking technology monitors eye movement trajectories to reveal the cognitive mechanisms underlying visual behavior.With advantages like objectivity and real-time capability,it is increasingly applied in nursing.However,research and application in China are still in the early stages.This article reviews the development,measurement metrics,methods,and impact of eye-tracking in nursing,analyzes current challenges,and suggests solutions to aid its development in the field of nursing in China.
6.Application and exploration of single-incision plus one port laparoscopic surgery in radical resection of colorectal cancer
Yu ZHU ; Hao WANG ; Yanan WANG ; Haijun DENG ; Tingyu MOU
Chinese Journal of Digestive Surgery 2025;24(6):733-738
The surgical management of colorectal cancer has evolved from conventional multiport laparoscopic surgery toward more minimally invasive and individualized approaches. Among these, single-incision laparoscopic surgery (SILS) or reduced-port laparoscopic surgery (RPLS) has gained increasing attention from clinicians. Single-incision plus one port laparoscopic surgery (SILS+1) combines the advantages of both SILS and RPLS. Recent studies have demonstrated that compared with conventional multiport laparoscopic surgery, SILS+1 could yield comparable safety, feasibility and oncologic outcomes in treating colorectal cancer while offering additional benefits in enhanced recovery and better cosmesis.The development of SILS+1 relies heavily on innovations in single-port platforms and specialized instruments. By strictly adhering to its indica-tions, skillfully employing string and traction techniques during surgery, and the appropriate mana-gement of complications such as hemorrhage, the procedure can be performed safely and smoothly. The authors review relevant domestic and international studies and integrate the practical experi-ence to provide an in-depth discussion on the application and exploration of SILS+1 in radical colorectal cancer surgery, aiming to provide valuable insights for broader adoption of this approach.
7.Research progress in treatment of symptomatic non-acute middle cerebra artery arteriosclerosis occlusion
Chenyang HUANG ; Tingyu LIU ; Qingfeng ZHU
Clinical Medicine of China 2025;41(2):155-160
In the non-acute phase, when the collateral circulation is poorly compensated due to atherosclerotic occlusion of the middle cerebral artery, it can lead to significant neurological dysfunction and a higher recurrence rate of stroke. Traditional treatments primarily involve managing risk factors and administering symptomatic pharmacotherapy, yet the outcomes are often unsatisfactory. In recent years, with the development of endovascular interventional techniques and interventional materials, microsurgical anastomosis, techniques, and the present of distal ischemic modulation, the treatment of symptomatic arteriosclerosis occlusion of the non-acute middle cerebral artery is attracting more and more attention in the field. This article reviews the progress of the treatment of symptomatic arteriosclerosis occlusion of the non-acute middle cerebral artery. For the surgical treatment of symptomatic non-acute middle cerebral artery atherosclerosis occlusion (SNMCAO) in non-acute phase, the superior temporal artery middle cerebral artery (STA-MCA) low flow bypass and intravascular interventional recanalization have their own advantages. For patients with short expected occlusion time, short occlusion segment, straight blood vessels, and good distal vascular bed, they may be more inclined to undergo endovascular recanalization treatment, otherwise they may choose STA-MCA low flow bypass surgery. Regardless of which treatment method is chosen, precise individualized evaluation must be conducted before surgery to select an individualized surgical approach that can maximize the benefits for patients with SNMCAO.
8.Research progress of proteomics related to diabetic foot
Shujie ZHOU ; Ling ZHAO ; Fangling ZHU ; Tingyu KE
Chinese Journal of Diabetes 2024;32(2):137-140
Diabetic foot(DF)is one of the most severe chronic complications of diabetes mellitus(DM),and it is an important cause of disability and mortality inpatients with DM.Changes in proteins in the tissues,organs and circulation of organisms can serve as microscopic reflections of the disease development process.Proteomics is an important technologyto explore the pathogenesis and treatment mechanism of dis-ease,and to find potential therapeutic targets and prognostic biomarkers of diseases.This article reviews the progress of proteomics research in DF.
9.Clinical Efficacy of Maiwei Yangfei Decoction in the Treatment of Idiopathic Pulmonary Fibrosis of Qi-Yin Deficiency Type
Dongwei ZHU ; Qi ZHAO ; Le BAI ; Tingyu PAN ; Jing WANG ; Shenhao GUO ; Yong XU ; Xianmei ZHOU
Journal of Nanjing University of Traditional Chinese Medicine 2024;40(9):962-969
OBJECTIVE To explore the therapeutic effect and safety of Maiwei Yangfei Decoction(MWYF)in the treatment of idiopathic pulmonary fibrosis of qi-yin deficiency type.METHODS A total of 58 patients with idiopathic pulmonary fibrosis of qi-yin deficiency type were randomly divided into an experimental group and a control group with 29 cases in each group according to a 1:1 ratio.Two cases dropped out of the experimental group and three cases dropped out of the control group.The control group received standardized treatment of Western medicine,and the experimental group received MWYF on the basis of the treatment of the control group.The treatment course of both groups was 3 months.The TCM syndrome score,lung function,6-minute walking distance(6MWD),transcutaneous blood oxygen saturation(SpO2),high-resolution computed tomography(HRCT)score,St.George's respir-atory questionnaire(SGRQ)score and serum sialoglycoprotein antigen(KL-6)level of the two groups were compared before and after treatment.Blood routine and liver and kidney function of the two groups were detected before and after treatment,and the occurrence of adverse reactions during treatment was recorded.RESULTS After treatment,the total score of TCM syndrome of the two groups was significantly improved(P<0.01),and the experimental group was better than the control group(P<0.01);the DLCO%of the experi-mental group increased(P<0.05),and the experimental group was higher than the control group(P<0.05).The experimental group showed significant improvement in 6MWD,HRCT grid shadow,SGRQ symptom score and total score,and serum KL-6 level(P<0.05,P<0.01),which was better than the control group(P<0.05,P<0.01).No serious adverse events occurred in either group dur-ing the treatment.CONCLUSION MWYF combined with standardized Western medicine treatment can effectively improve the clini-cal symptoms of patients with idiopathic pulmonary fibrosis of qi-yin deficiency type,reduce the expression level of serum KL-6,and has a definite effect and good safety.
10.National Metabolic Management Center(MMC) comprehensive management standards for patients with diabetes, hypertension, and hyperlipidemia
Weiqing WANG ; Yufan WANG ; Guixia WANG ; Aifang WANG ; Chunfang WEN ; Fanrong TIAN ; Guang NING ; Ping FENG ; Dalong ZHU ; Libin LIU ; Bangqun JI ; Heng SU ; Jianling DU ; Shu LI ; Yunsong LI ; Liu YANG ; Li LI ; Shengli WU ; Jinsong KUANG ; Yubo SHA ; Ping ZHANG ; Yawei ZHANG ; Yifei ZHANG ; Qidong ZHENG ; Zhongyan SHAN ; Dong ZHAO ; Zhigang ZHAO ; Tingyu KE ; Yu SHI ; Xuejiang GU ; Ning XU ; Fengmei XU ; Zuhua GAO ; Rong TANG ; Qijuan DONG ; Songbo FU ; Yi SHU ; Weici XIE ; Yuancheng DAI
Chinese Journal of Endocrinology and Metabolism 2024;40(12):1007-1023
Diabetes, hypertension, and dyslipidemia, collectively referred to the " Three Highs, " represent increasingly prevalent metabolic risk factors in China. Many individuals experience all three conditions concurrently, significantly heightening the risk of cardiovascular disease and mortality. Although the National Metabolic Management Center(MMC) has been established for over eight years and has its unique features, the awareness, treatment, and control rates of these diseases in China remain low, and the efficiency of community management is insufficient. According to the previous two editions of management guidelines and the most recent domestic and international diagnostic and treatment guidelines, this paper conducts an in-depth analysis of the operational experience and management strategies of the MMC. Its aim is to improve the efficiency of grassroots MMC mode management for " Three Highs" patients and ensure that patients receive more standardized management.


Result Analysis
Print
Save
E-mail